Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandostatin in Acromegaly Post-Surgery
NCT02427295Phase 4Unknown
- Sponsor
- Asan Medical Center
- Start
- Mar 2014
- Primary completion
- Dec 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of Octreotide long-acting injection in acromegaly, sponsored by Asan Medical Center. Status: unknown.
02
Drugs
Octreotide long-acting injection
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT02427295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427295.